Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a non » _ non (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a non » _ non (Expand Search)
-
861
-
862
-
863
-
864
NAC prevents VMH GI neuron activation by decreased glucose.
Published 2013“…(B) Percentage of VMH GI neurons from S<sup>3</sup>S or I<sup>3</sup>S rats pre-treated or not with NAC which depolarized in response to a 2.5–0.7 mM glucose decrease quantified using changes in FLIPR-MPD fluorescence intensity. *: p<0.05 (Two-way ANOVA; group differences were determined by One-Way ANOVA followed by Bonferoni post-hoc test).…”
-
865
-
866
-
867
Hematopoietic potential decreases in ESC with down-regulation of junction molecules.
Published 2011“…CD45 expression was analyzed flow cytometrically using anti-CD45 conjugated to PerCP-Cy5.5. Non-viable cells were excluded based on DAPI fluorescence. …”
-
868
Loss of Cntnap2 decreases specifically stabilization of new spines.
Published 2015“…<p><b>a.</b> From left to right: Chronic imaging through a cranial window of L5 pyramidal neuron. …”
-
869
Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype.
Published 2014“…Values are means +/− standard error (n = 6 MMTV-Wnt1, 3 fields per tumor; n = 5 MMTV-Wnt1;MMTV-Wnt5a, 3 fields per tumor). MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
-
870
-
871
-
872
-
873
-
874
-
875
Image 5_Behavioral and biochemical changes associated with the analgesic effects of (2R,6R)-hydroxynorketamine alone and in combination with meloxicam following disk puncture in mi...
Published 2025“…Our finding supports further study of the clinical potential of (2R,6R)-Hydroxynorketamine as a non-opioid analgesic for discogenic back pain.…”
-
876
-
877
-
878
-
879
-
880